CAR T-cell therapy is an immune-reprogramming procedure that turns a patient’s own immune cells into cancer-fighting specialists. The entire process is complex, but researchers have now found a faster way to achieve similar effects using a single intravenous (IV) drip of a harmless engineered virus.
In the standard process, clinicians extract T cells from the patient’s blood, then re-engineer them in the lab, arming each one with a chimeric antigen receptor (CAR)—engineered proteins designed to recognize specific markers on cancer cells...
Read More
Recent Comments